METACRINE INC Share - Company Data & Prices - US59101E1038 | MoneyPeak

METACRINE INC

Share · US59101E1038 · MTCR (XNAS)

Analyst Grade Summary

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

0

1

2

0

0

No Price

Company Profile for METACRINE INC Share

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

AI Analysis of METACRINE INC

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of METACRINE INC

No AI threads available for this company yet.

Company Data

Name METACRINE INC

Company Metacrine, Inc.

Symbol MTCR

Website https://www.metacrine.com

Primary Exchange

NASDAQ

ISIN US59101E1038

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO David M. Maggio

Country United States of America

Currency USD

Employees 0,0 T

Address 3985 Sorrento Valley Boulevard, 92121 San Diego

IPO Date 2020-09-16

Dividends from 'METACRINE INC'

Ex-Date	Dividend per Share
21.06.2023	0,58 USD

Ticker Symbols

Name	Symbol
NASDAQ	MTCR

More Shares

Investors who hold METACRINE INC also have the following shares in their portfolio:

Quantum Software S.A. Share

UNEDIC 19/29 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2026